Global Peptide Receptor Radionuclide Therapy (PRRT) Market Growth (Status and Outlook) 2025-2031

December 2025 | 89 pages | ID: GE741084EDC4EN
LP Information

Abstracts

According to this study, the global Peptide Receptor Radionuclide Therapy (PRRT) market size will reach US$ 6062 million by 2031.

Peptide receptor radionuclide therapy (PRRT) is a type of molecular therapy, also known as radioisotope therapy that is used for treating neuroendocrine tumors.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Peptide Receptor Radionuclide Therapy (PRRT) Industry Forecast” looks at past sales and reviews total world Peptide Receptor Radionuclide Therapy (PRRT) sales in 2024, providing a comprehensive analysis by region and market sector of projected Peptide Receptor Radionuclide Therapy (PRRT) sales for 2025 through 2031. With Peptide Receptor Radionuclide Therapy (PRRT) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Receptor Radionuclide Therapy (PRRT) industry.

This Insight Report provides a comprehensive analysis of the global Peptide Receptor Radionuclide Therapy (PRRT) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide Receptor Radionuclide Therapy (PRRT) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide Receptor Radionuclide Therapy (PRRT) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Receptor Radionuclide Therapy (PRRT) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Receptor Radionuclide Therapy (PRRT).

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Receptor Radionuclide Therapy (PRRT) market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Gastroenteropancreatic Neuroendocrine Tumor
• Foregut Neuroendocrine Tumor
• Midgut Neuroendocrine Tumor
• Hindgut Neuroendocrine Tumor

Segmentation by Application:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bayer
• Novartis
• Lantheus
• Aurobindo Pharma
• Mundipharma
• Curium Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2020-2031)
  2.1.2 Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Peptide Receptor Radionuclide Therapy (PRRT) by Country/Region (2020, 2024 & 2031)
2.2 Peptide Receptor Radionuclide Therapy (PRRT) Segment by Type
  2.2.1 Gastroenteropancreatic Neuroendocrine Tumor
  2.2.2 Foregut Neuroendocrine Tumor
  2.2.3 Midgut Neuroendocrine Tumor
  2.2.4 Hindgut Neuroendocrine Tumor
2.3 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type
  2.3.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2020-2025)
2.4 Peptide Receptor Radionuclide Therapy (PRRT) Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application
  2.5.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2020-2025)

3 PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) MARKET SIZE BY PLAYER

3.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Player
  3.1.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Player (2020-2025)
  3.1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Player (2020-2025)
3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) BY REGION

4.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2020-2025)
4.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2020-2025)
4.4 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2020-2025)
4.5 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2020-2025)
4.6 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2020-2025)
5.2 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2020-2025)
5.3 Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2020-2025)
6.2 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2020-2025)
6.3 APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2020-2025)
7.2 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2020-2025)
7.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) by Region (2020-2025)
8.2 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2020-2025)
8.3 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) MARKET FORECAST

10.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Region (2026-2031)
  10.1.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Region (2026-2031)
  10.1.2 Americas Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.1.3 APAC Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.1.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.1.5 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.2 Americas Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Country (2026-2031)
  10.2.1 United States Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.2.2 Canada Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.2.3 Mexico Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.2.4 Brazil Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.3 APAC Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Region (2026-2031)
  10.3.1 China Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast
  10.3.2 Japan Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.3.3 Korea Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.3.4 Southeast Asia Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.3.5 India Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.3.6 Australia Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Country (2026-2031)
  10.4.1 Germany Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.4.2 France Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.4.3 UK Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.4.4 Italy Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.4.5 Russia Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.5 Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Region (2026-2031)
  10.5.1 Egypt Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.5.2 South Africa Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.5.3 Israel Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
  10.5.4 Turkey Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast
10.6 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Type (2026-2031)
10.7 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Peptide Receptor Radionuclide Therapy (PRRT) Forecast

11 KEY PLAYERS ANALYSIS

11.1 Bayer
  11.1.1 Bayer Company Information
  11.1.2 Bayer Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
  11.1.3 Bayer Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Bayer Main Business Overview
  11.1.5 Bayer Latest Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
  11.2.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis Latest Developments
11.3 Lantheus
  11.3.1 Lantheus Company Information
  11.3.2 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
  11.3.3 Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Lantheus Main Business Overview
  11.3.5 Lantheus Latest Developments
11.4 Aurobindo Pharma
  11.4.1 Aurobindo Pharma Company Information
  11.4.2 Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
  11.4.3 Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Aurobindo Pharma Main Business Overview
  11.4.5 Aurobindo Pharma Latest Developments
11.5 Mundipharma
  11.5.1 Mundipharma Company Information
  11.5.2 Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
  11.5.3 Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Mundipharma Main Business Overview
  11.5.5 Mundipharma Latest Developments
11.6 Curium Pharmaceuticals
  11.6.1 Curium Pharmaceuticals Company Information
  11.6.2 Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
  11.6.3 Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Curium Pharmaceuticals Main Business Overview
  11.6.5 Curium Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Peptide Receptor Radionuclide Therapy (PRRT) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Gastroenteropancreatic Neuroendocrine Tumor
Table 4. Major Players of Foregut Neuroendocrine Tumor
Table 5. Major Players of Midgut Neuroendocrine Tumor
Table 6. Major Players of Hindgut Neuroendocrine Tumor
Table 7. Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2020-2025)
Table 10. Peptide Receptor Radionuclide Therapy (PRRT) Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2020-2025)
Table 13. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Player (2020-2025)
Table 15. Peptide Receptor Radionuclide Therapy (PRRT) Key Players Head office and Products Offered
Table 16. Peptide Receptor Radionuclide Therapy (PRRT) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region (2020-2025)
Table 21. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Country (2020-2025)
Table 25. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2020-2025)
Table 27. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2020-2025)
Table 29. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region (2020-2025)
Table 31. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Country (2020-2025)
Table 35. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Peptide Receptor Radionuclide Therapy (PRRT)
Table 41. Key Market Challenges & Risks of Peptide Receptor Radionuclide Therapy (PRRT)
Table 42. Key Industry Trends of Peptide Receptor Radionuclide Therapy (PRRT)
Table 43. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Bayer Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 48. Bayer Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 49. Bayer Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Bayer Main Business
Table 51. Bayer Latest Developments
Table 52. Novartis Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 53. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 54. Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Novartis Main Business
Table 56. Novartis Latest Developments
Table 57. Lantheus Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 58. Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 59. Lantheus Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Lantheus Main Business
Table 61. Lantheus Latest Developments
Table 62. Aurobindo Pharma Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 63. Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 64. Aurobindo Pharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Aurobindo Pharma Main Business
Table 66. Aurobindo Pharma Latest Developments
Table 67. Mundipharma Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 68. Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 69. Mundipharma Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Mundipharma Main Business
Table 71. Mundipharma Latest Developments
Table 72. Curium Pharmaceuticals Details, Company Type, Peptide Receptor Radionuclide Therapy (PRRT) Area Served and Its Competitors
Table 73. Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Product Offered
Table 74. Curium Pharmaceuticals Peptide Receptor Radionuclide Therapy (PRRT) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Curium Pharmaceuticals Main Business
Table 76. Curium Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Peptide Receptor Radionuclide Therapy (PRRT) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Peptide Receptor Radionuclide Therapy (PRRT) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Country/Region (2024)
Figure 8. Peptide Receptor Radionuclide Therapy (PRRT) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type in 2024
Figure 10. Peptide Receptor Radionuclide Therapy (PRRT) in Hospital Pharmacies
Figure 11. Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 12. Peptide Receptor Radionuclide Therapy (PRRT) in Retail Pharmacies
Figure 13. Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 14. Peptide Receptor Radionuclide Therapy (PRRT) in Online Pharmacies
Figure 15. Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Online Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application in 2024
Figure 17. Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Player in 2024
Figure 18. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region (2020-2025)
Figure 19. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2020-2025 ($ millions)
Figure 20. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2020-2025 ($ millions)
Figure 21. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2020-2025 ($ millions)
Figure 23. Americas Peptide Receptor Radionuclide Therapy (PRRT) Value Market Share by Country in 2024
Figure 24. United States Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region in 2024
Figure 29. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2020-2025)
Figure 30. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2020-2025)
Figure 31. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 35. India Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Country in 2024
Figure 38. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2020-2025)
Figure 39. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2020-2025)
Figure 40. Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 41. France Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 54. APAC Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 55. Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 57. United States Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 58. Canada Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 59. Mexico Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 60. Brazil Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 61. China Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 62. Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 63. Korea Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 65. India Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 66. Australia Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 67. Germany Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 68. France Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 69. UK Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 70. Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 71. Russia Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 72. Egypt Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 73. South Africa Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 74. Israel Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 75. Turkey Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)
Figure 76. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Peptide Receptor Radionuclide Therapy (PRRT) Market Size 2026-2031 ($ millions)